• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00513750
Device Problems Activation, Positioning or Separation Problem (2906); Material Integrity Problem (2978)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/04/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(6).(b)(4).The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device.If there is any further relevant information from that review, a supplemental mdr will be filed.
 
Event Description
It was reported to boston scientific corporation on july 8, 2019 that an ultraflex esophageal ng distal release covered stent was to be used to treat a 6 cm stricture in the esophagus due to esophageal cancer with tracheoesophageal fistula during an esophageal stent placement procedure performed on (b)(6) 2019.Reportedly, the patient's anatomy was tortuous.According to the complainant, during the procedure, the stent deployment suture was stuck and could not be pulled further.The stent was partially deployed when removed from the patient.A photo was provided and showed a small hole in the distal stent cover.The procedure was completed with another ultraflex esophageal stent.There were no patient complications reported as a result this event.Tha patient's condition following the procedure was reported to be stable.
 
Event Description
It was reported to boston scientific corporation on july 8, 2019 that an ultraflex esophageal ng distal release covered stent was to be used to treat a 6 cm stricture in the esophagus due to esophageal cancer with tracheoesophageal fistula during an esophageal stent placement procedure performed on (b)(6) 2019.Reportedly, the patient's anatomy was tortuous.According to the complainant, during the procedure, the stent deployment suture was stuck and could not be pulled further.The stent was partially deployed when removed from the patient.A photo was provided and showed a small hole in the distal stent cover.The procedure was completed with another ultraflex esophageal stent.There were no patient complications reported as a resul this event.Tha patient's condition following the procedure was reported to be stable.
 
Manufacturer Narrative
Block e1: initial reporter phone: (b)(6).Block h6: problem code 2978 captures the reportable event of stent cover damaged.Block h10: an ultraflex esophageal ng distal release covered stent and delivery system were received for analysis.Visual analysis of the returned device found the stent was received partially deployed.A photo was provided and showed a hole at the distal end of the stent, also a significant quantity of blood was noted at the stent, however, upon product analysis no issues were noted with the stent cover.Functional evaluation revealed that it was possible to deploy the stent by manually pulling the finger ring to release with no difficulty.The stent was measured and was found to be within specifications.No other issues with the stent and delivery system were noted.The reported failure of stent cover damage could not be confirmed.Device analysis identified no damage to the stent cover.Possibly, the supposed hole found in the photo is not an actual hole but an effect caused by blood.The stent was received partially deployed.Taking all available information into consideration, the investigation concluded that the reported event was likely due to anatomical or procedural factors such as, characteristics of the lesion, handling of the device, the technique used by the user and normal procedural difficulties encountered during the procedure, which limited the performance of the device.Therefore, the most probable root cause is adverse event related to procedure.A review of the device history record (dhr) was performed and confirmed that this device met all material, assembly, and performance specifications at the time of release for distribution.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX ESOPHAGEAL NG
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key8861962
MDR Text Key153688751
Report Number3005099803-2019-03792
Device Sequence Number1
Product Code ESW
UDI-Device Identifier08714729649113
UDI-Public08714729649113
Combination Product (y/n)N
PMA/PMN Number
K091816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 09/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/05/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/08/2020
Device Model NumberM00513750
Device Catalogue Number1375
Device Lot Number0022228859
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/19/2019
Date Manufacturer Received08/14/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age66 YR
Patient Weight45
-
-